Our hypothesis is that fork slowdown by PARP1 favors stalled fork stabilization in resistant CRC-SCs, providing extra-time to limit ssDNA accumulation and resolve endogenous RS. The gene discussed is PARP1; the disease is colorectal carcinoma.